Company Name:Cerus Corporation
CEO: William M. Greenman

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: Cerus Corp is a biomedical products company. It is engaged in developing and commercializing the INTERCEPT Blood System to enhance blood safety.


Key numbers

Market Capitalization:571110540
Shares Outstanding: 140322000
Float: 137011243
Next Earning Date:2020-03-03
TTm EPS: -0.5107
TTm Dividend Rate:
200 days moving average:5.01
50 days moving average: 4.23
One day percent Change: 4.19



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,